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Abstract
Background: Most studies measure the impact of ischemic heart disease (IHD) on individuals using quality of life
metrics such as disability-adjusted life-years (DALYs); however, IHD also has an enormous impact on productive life
years (PLYs). The objective of this study was to project the indirect costs of IHD resulting from lost PLYs to older
Australian workers (45–64 years), government, and society 2015–2030.
Methods: Nationally representative data from the Surveys of Disability, Ageing and Carers (2003, 2009) were used
to develop the base population in the microsimulation model (Health&WealthMOD2030), which integrated data
from established microsimulation models (STINMOD, APPSIM), Treasury’s population and workforce projections, and
chronic conditions trends.
Results: We projected that 6700 people aged 45–64 were out of the labour force due to IHD in 2015, increasing to
8100 in 2030 (21 increase). National costs consisted of a loss of AU$273 (US$263) million in income for people with
IHD in 2015, increasing to AU$443 ($US426) million (62% increase). For the government, extra welfare payments
increased from AU$106 (US$102) million in 2015 to AU$143 (US$138) million in 2030 (35% increase); and lost
income tax revenue increased from AU$74 (US$71) million in 2015 to AU$117 (US$113) million in 2030 (58%
increase). A loss of AU$785 (US$755) million in GDP was projected for 2015, increasing to AU$1125 (US$1082)
million in 2030.
Conclusions: Significant costs of IHD through lost productivity are incurred by individuals, the government, and
society. The benefits of IHD interventions include not only improved health but also potentially economic benefits as
workforce capacity.
Keywords: Cardiovascular disease, Microsimulation, Ischemic heart disease, Productivity, Indirect costs, Income
Background
Ischemic or coronary heart disease (IHD) is a group of
health conditions that includes: stable angina, unstable
angina, acute myocardial infarction, and sudden cardiac
death. IHD has an enormous burden on individuals glo-
bally, which has been measured in terms of years of life
lost from IHD deaths and years of disability lived with 3
nonfatal IHD sequelae: nonfatal acute myocardial infarc-
tion, angina pectoris, and ischemic heart failure. The
global burden of IHD increased by 29 million disability-
adjusted life-years (DALYs) between 1990 and 2010 – a
29% increase [1].
Global burden of disease studies project the significant
reductions in quantity and quality of life due to IHD at
national, regional and global levels. However, national
governments and supranational economic/public health
organisations (such as the Organisation for Economic
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Co-operation and Development (OECD) and the World
Health Organisation (WHO)) also emphasise the signifi-
cant impacts of chronic conditions (such as IHD) on pro-
ductive life years (PLYs) – where lost PLYs due to IHD are
defined as the number of people who are out of the labour
force due to IHD on an annual basis [2] – resulting in in-
direct costs for individuals (lost income) and the govern-
ment (extra welfare payments and lost income tax
revenue) in addition to direct (healthcare) costs [3, 4].
The direct health care costs of IHD are larger than the
costs for any other chronic disease group [5, 6]; however,
the indirect costs of IHD through lost labour force par-
ticipation are likely to be equally as large as the direct
costs. Initial events of IHD can have a significant impact
on the physical and psychological ability of individuals
[7, 8] which may also impact on their ability to remain
in the labour force and their economic survival, with
these impacts increasing as repeated events occur.
While WHO has defined health as “a state of complete
physical, mental and social well-being and not merely
the absence of disease or infirmity” for more than 60
years (WHO 1946 in Cowie (2016) [9]), studies on the
impact of chronic conditions on labour force participa-
tion have only recently emerged (see, for cardiovascular
disease (CVD) costs for Europe, [10, 11]; and for
Australia, [12, 13]). This is despite the fact that labour
force participation is not only important economically
but also as an indicator of physical functioning and psy-
chological metrics (such as self-esteem and connected-
ness) in individuals with chronic conditions [9].
One of the major challenges facing governments in
Australia and elsewhere is the ageing population, which
leads to increased demand for health care but ageing of
the workforce also impacts on the income tax to fund
health care and other essential services. For these rea-
sons, the Australian Government (and others) have im-
plemented a range of polices to encourage older workers
(also known as mature age workers and typically defined
as being 45–64 years of age by the Australian Bureau of
Statistics although other agencies sometimes use 50–64
or 55–64 years [14]) to remain longer in the work force,
including raising the official retirement age. However,
these polices may not be sufficient to ensure that people
remain longer in the work force if their ill-health is pre-
venting them from doing so.
Since the incidence of IHD increases with age [5, 15],
older workers (45–64 years) are more likely to incur dis-
ability related to these events which impacts on their
working capacity. In our previous study, we found that
CVD (includes IHD) has a significant and enduring im-
pact on the labour force participation of older workers
(45–64 years). In particular, we estimated that 7% of
older workers were out of the labour force due to IHD
in both 2010 (25,000) and 2030 (30,000), making IHD
the fourth most common chronic disease causing early
retirement among this age group [2]. Workers with
CVD are also more likely to have their employment af-
fected by disease-related outcomes [15]. Many countries
are confronted with similar challenges with regard to the
ageing workforce, and hence have the same need to plan
for increased economic losses due to chronic diseases
such as IHD [8, 9, 16].
In our previous study, we projected the PLYs lost due
to chronic health conditions (including IHD) for people
aged 45–64 years [2]. The aim of this study is to project
the indirect costs of IHD among Australians aged 45–
64 years from 2015 to 2030 using Australia’s first micro-
simulation model on the economic impacts of ill-health,
Health&WealthMOD2030. It is the first study in
Australia and internationally to project the indirect costs
of IHD based on the individual’s lost labour force par-
ticipation and lost income (as opposed to average earn-
ings); the government’s costs through lost income tax
revenue and extra welfare payments; and society’s cost
through lost GDP due to lost PLYs from IHD, out to
2030. While developing the modelling infrastructure
used in this study is a large undertaking, many countries
have models using similar methods, and others may see
the use for investing in developing these models, upon
reading our paper. Additionally, there has been a recent
change in the United States’ recommendations on cost-
effectiveness analysis which emphasises moving from
not including productivity costs to now including them
[17, 18]. This change highlights a particular need for the
type of cost inputs that the current study presents.
Methods
The microsimulation model
The output data of a static microsimulation model called
Health&WealthMOD2030 – Australia’s first microsimu-
lation model of the long-term economic impacts of
chronic disease in the population aged 45–64 years –
was used to analyse the impacts of IHD on labour force
participation, personal income, and government revenue
and welfare payments at four time-points (2015, 2020,
2025 and 2030). The main data sources, statistical
methods and other details about the development of
Health&WealthMOD2030 are discussed in Schofield et
al. (2014) [19]; go to https://www.microsimulation.org/
IJM/V7_2/4_IJM_7_2_2014_Schofield_et_al.pdf. Figure 1
provides a graphical representation of the microsimula-
tion model (Health&WealthMOD2030) used in this
study.
Data
Base population
The base population of Health&WealthMOD2030 is unit
record data from two Surveys of Disability, Ageing and
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Carers (SDAC), 2003 and 2009, conducted every 6 years
by the Australian Bureau of Statistics (ABS) [20]. The
SDACs are nationally representative household surveys
and provide the most complete data on individuals with
chronic disease or disability [20, 21]. From these data,
individual records were extracted for everyone aged 45–
64 years. The information extracted for each individual
consisted of personal variables (age, sex, and family
type), socioeconomic variables (education, income, re-
ceipt of welfare payments and type of payments), labour
force variables (labour force participation and hours of
work), and health variables (main chronic condition).
The ABS Microdata Review Panel approved SDAC 2003
and 2009 usage.
Source for indirect costs
Economic data were sourced from a well-established Aus-
tralian microsimulation model, the Static Incomes Model
(STINMOD), developed by the National Centre for Social
and Economic Modelling (NATSEM) at the University of
Canberra, Australia [22]. STINMOD is the country’s fore-
most income and tax/transfer microsimulation model
used to assess the potential distributional consequences of
implementing the Australian Government’s tax and cash
transfer (welfare payment) policies [23].
Income, welfare, tax and wealth information was im-
puted onto the base population by identifying individuals
with similar characteristics on STINMOD and “donating”
their economic information onto Health&Wealth-
MOD2030 via a modelling approach regularly used in
microsimulation called synthetic matching [24]. In the
matching approach, ten variables were used: sex, age
group, income unit type, income quintile, receipt of aged
pension, receipt of disability support pensions, labour
force status, hours of work per week, highest level of
qualification attained, and home ownership. All of these
variables were provided in both datasets and they were
strongly related to personal income, which is the reason
why they were selected as matching variables; see Scho-
field et al. (2014) for a description of the work undertaken
on this aspect of the microsimulation modelling and re-
sults confirming the validity of the synthetic matching
undertaken in Health&WealthMOD2030 [19].
Income and tax data from STINMOD in 2013 were
indexed to reflect economic growth projections from 2013
to the projection years of 2015, 2020, 2025, and 2030. In-
come and taxes paid by individuals were assumed to grow
at a rate of 1% per annum in real terms (i.e. 1% above
Consumer Price Index [CPI]) based on information in
Treasury (2015) [25]. Welfare payments were assumed to
grow in line with national CPI growth (i.e. zero real
growth) [26]. Real GDP is defined as growth above CPI.
Population and labour force growth
The Australian Treasury provided population and labour
force projections, which were used to account for trends
Fig. 1 Graphical representation of Health&WealthMOD2030
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in these variables from 2015 to 2030. We extracted
population projections and projected the rates of full-
time and part-time employment for men and women
aged 45–64 years by five year age groups from 2015 to
2030.
We used Treasury’s population projections to provide
comparable evidence of the long-term economic impacts
of IHD based on the model. Since Treasury’s population
projections can only be separated out by a two socio-
demographic variables (age group and sex), we applied
the projected age-sex specific distributions of other
socio-demographic variables (such as education) from a
second established microsimulation model, the Austra-
lian Population and Policy Simulation Model (APPSIM)
[27], to the Treasury’s population projections to project
socio-demographic profiles of the Australian population
in 2015, 2020, 2025 and 2030.
APPSIM is a dynamic microsimulation model devel-
oped by NATSEM in collaboration with several Austra-
lian Government departments. The model is used to
simulate all major events that occur over the lifetimes of
Australians, which are derived from probabilities of par-
ticular events occurring to real people. The projected
distributions of socio-demographic variables for 2015,
2020, 2025 and 2030 thus stem from APPSIM.
Chronic disease trends
Trends in chronic disease incidence used in Begg et al.
(2008) – i.e. the 2003 Australian Burden of Disease and
Injury Study [28] – were applied to the base population.
Specifically, this study applied chronic disease trends
from 2003 until 2023, after which time prevalence rates
were assumed to stabilise as per Begg et al. (2008) [28].
We calculated proportional changes in chronic disease
prevalence and applied these to the corresponding dis-
eases in the base population, which were aggregated into
the following diseases: stroke, cancer (almost stable in
men and women), ischaemic heart disease (decreasing
trend in men and women), type 2 diabetes (increasing
trend in men and women) and chronic obstructive pul-
monary disease (stable trend in men; increasing trend in
women). Based on proportional changes, the prevalence
of chronic disease among Australians aged 45–64 was
projected for 2015 and 2030 by 5 year age group and
sex.
In Australia, the death rate due to heart disease has
been declining over the last four decades. For example,
in 1968, the death rate for heart disease was 428.3 deaths
per 100,000 persons whereas the latest reported rate is
66.1 per 100,000 persons in 2015. The decrease in the
death rate has been attributed to a variety of factors,
such as improvements in diagnosis, enhancements in
treatment (including an increase in the use of medica-
tions to treat high cholesterol and blood pressure) and
behavioural changes that have resulted in people being
placed at lower risk of not only developing but also
dying from the disease (e.g. higher smoking cessation
rates) (AIHW 2014) [29]. For those with established
IHD, it has been advancements in treatment that have
meant a reduction in coronary events such as heart at-
tacks, and led to improved rates of survival after these
type of events occur (AIHW 2014) [29].
Reweighting
The SDAC data were reweighted using a reweighting al-
gorithm called GREGWT – which was developed by the
ABS for reweighting its household survey data [30] – to
account for demographic and other changes in the
population between 2003 and 2009. This reweighting al-
gorithm was also used to weight the data for every 5
years between 2010 and 2030. Thus the reweighted data
represent the Australian population aged 45–64 years in
2015, 2020, 2025 and 2030.
Health&WealthMOD2030 is a static microsimulation
model. It uses static ageing techniques, changing certain
variables on the original basefile to produce an output
file with the demographic and economic characteristics
expected in future years. Person weights are modified to
change the total population and the weighted character-
istics of the population to take into account the popula-
tion ageing and change in labour force participation
rates; incomes, relevant welfare payments are adjusted
for real price changes; and prevalence of chronic disease
is changed to match the prevalence rates trends in the
Australian Burden of Disease 2003 Study (Begg et al.
2008) [28]. The simulations are then run on the aged
basefile data (micro-level data) to estimate the impact of
exiting labour force due to IHD on economic outcomes
(such as income, taxes, welfare payments) in the future
years (2015, 2020, 2025, 2030).
Lost productive life years due to IHD
In the SDACs 2003 and 2009, respondents were asked
to nominate their current labour force status as either:
1. Employed working full-time
2. Employed working part-time
3. Unemployed looking for full-time work
4. Unemployed looking for part-time work
5. Not in the labour force
6. Not applicable
For those who responded they were not in the labour
force, the main reason for them not looking for work
was also sought; in particular, whether they were out of
the labour force because of their ‘own ill-health or dis-
ability’. Note that the nature of the disability was not
specified in this SDAC question. Persons in this group
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were identified as having lost a PLY in that year. All sur-
vey respondents were asked whether they have a chronic
disease, and to nominate the type of disease they have
from a list of 80 diseases and injuries.
Respondents’ main chronic diseases were classified in
the SDACs 2003 and 2009 by the ABS using ICD10
codes. Those who reported having heart disease, angina
or myocardial infarction were considered to have IHD in
this study. Individuals identified as being out of the
labour force due to ill-health and having any of the
above health conditions as their main chronic condition
were considered to have lost PLYs due to IHD [20, 21].
It should be noted that lost productive life years (PLYs)
is a relatively new metric of disease burden, and one that
we have valued in terms of lost income (dollars) to indi-
viduals, extra welfare payments and lost tax revenue to
the government, and lost GDP to society. For this rea-
son, we wish to specify the definition of lost PLYs due to
chronic conditions when based on panel versus cross-
sectional data. The PLYs of an individual refers to the
number of years an individual is in employment before
reaching traditional retirement age (panel data).
Prevalence-based PLYs corresponds to the total number
of individuals in employment in any given year (cross-
sectional data). In our static microsimulation model, in-
dividuals who responded as “not in the labour force” due
to “their own ill-health or disability” and nominated any
of the diseases in the IHD group as their main chronic
condition were identified as having lost PLYs due to IHD
in a particular year.
Costs
Three indirect costs due to lost PLYs because of IHD were
projected to 2030: lost income for individuals with this
chronic condition, extra welfare payments, and lost tax
revenue for the government. Individual income is com-
prised of earnings, income from non labour market activ-
ities producing a return, and welfare payments. The Aged
Pension, Disability Support Pension, Newstart Allowance,
Carer Payment, and Family Tax Benefit are the main wel-
fare payments for Australians aged 45–64 years.(http://
www.humanservices.gov.au/customer/services). Personal
income tax (including the Medicare levy) defines the tax
measure used in this study.
Microsimulation
Configurations in projected lost labour participation due
to IHD and the related costs from 2015 to 2030 were ex-
plored using descriptive analysis. The mean (standard
deviation) and median weekly income, welfare payments,
and taxes were calculated for those aged 45–64 years
who were out of the labour force due to IHD or in the
labour force with and without IHD. Costs were stated in
real 2013 Australian dollars.
Differences in the indirect costs of those with lost
PLYs due to IHD compared to those employed full-time
or part-time who do not have IHD, were projected using
counterfactual microsimulation with Monte Carlo ap-
proaches. For each individual record of not in the labour
force due to IHD, a counterfactual was designated at
random with replacement from the group of individuals
employed full-time who do not have IHD. Matching of
records was based on sex, age group, and highest level
of educational attainment. These variables were selected
on the basis that they were repeatedly found to be key
variables explaining the differences in health outcomes
and healthcare use of people with IHD; see McSweeney
et al. (2016) [31] and Albert et al. (2014) [32]. A total of
1000 simulations were run, producing 1000 counterfac-
tual sets of data for those not in the labour force due to
IHD. The mean of these 1000 simulations and the 95%
confidence interval (CI) were estimated using the per-
centile approach.
This simulation approach was also applied for the se-
lection of counterfactuals from the group of individuals
employed part-time without IHD in order to project dif-
ferences in costs between those not in the labour force
due to IHD and employed part-time without IHD.
For estimation of the national costs, counterfactuals
were derived from the entire labour force group (i.e.
part-time or full-time employed and unemployed) who
were without IHD. Thus the total national income lost
was calculated based on the differences between the in-
come of individuals with lost PLYs due to IHD and those
employed full-time, part-time or unemployed who are
without IHD.
This study projects the income received by people
aged 45–64 who have lost PLYs due to IHD, the amount
of taxes paid and welfare payments received in 2015,
2020, 2025 and 2030. It quantifies the difference in these
costs between those who have lost PLYs due to IHD and
those in the labour force without these diseases in order
to provide a more comprehensive picture of the indirect
costs of IHD than is currently available (see [33]). Fur-
thermore, these comparisons enable computation of po-
tential cost savings (benefits) if these diseases could be
prevented or treated in a way that enabled labour force
participation.
We estimated lost GDP based on the estimated num-
ber of people out of the labour force due to IHD using
our model and Treasury’s projected working-age popula-
tion and GDP in each of the years using Treasury’s GDP
formula [34].
Results
The population aged 45–64 with lost PLYs due to IHD
Among the 5,945,000 people aged 45–64 years in
Australia in 2015, 6700 (0.11%) were out of the labour
Schofield et al. BMC Public Health          (2019) 19:802 Page 5 of 13
force due to IHD (i.e. had lost PLYs); 62,800 (1.06%)
were employed full-time with IHD; 23,900 (0.40%) were
employed part-time with IHD; 3,155,900 (53.08%) were
employed full-time without IHD; and 1,194,100 (20.09%)
were employed part-time without IHD. A further 1,501,
600 people were either not in the labour force due to ill-
health with their main chronic condition being some-
thing other than IHD, or unemployed or not in the
labour force due to reasons other than ill-health. Of the
86,700 workers who have IHD, 72.43% were working
full-time and 27.57% were working part-time (Table 1).
The economic circumstances of those with lost PLYs
due to IHD were notably worse than those in employ-
ment without IHD. Those who were out of the labour
force due to IHD had a median weekly income of
AU$415.83(US$399.97) in 2015, which is only about a
third of the median weekly income of those employed
full-time without IHD (AU$1305.46 or US$1255.67)
(Table 1). Those not in the labour force due to IHD re-
ceived a median of AU$321.87 (US$309.59) per week in
welfare payments in 2015, which is 77.40% of their total
income. Because they are not in paid employment, they
paid $0 in income taxes per week.
By 2030, the population of older workers (aged 45–64)
is projected to reach 7,130,200 (growth of 19.95%) and
consist of 8100 (0.11%) people out of the labour force
due to IHD (a 20.90% increase from 2015); 61,200
(0.86%) employed full-time with IHD (a 2.55% decrease
from 2015); 24,900 (0.35%) employed part-time with
IHD (a 4.18% increase from 2015); 3,917,800 (54.95%)
employed full-time without IHD (a 24.14% increase from
2015); 1,551,100 (21.75%) employed part-time without
IHD (a 29.90% increase from 2015). Those with lost
labour force participation due to IHD are projected to
receive AU$423.38 in total income per week in 2030; of
this total income, AU$365.52 ($US351.58) or 86.33%
consisted of welfare payments (Table 1, last column).
Thus those with lost PLYs due to IHD are expected to
not only experience relatively small growth in their in-
come (growth of only 1.82% from 2015) but also have a
larger proportion of their income consisting of welfare
payments (mainly the Disability Support Pension or
DSP) from 2015 to 2030, which suggests a deepening of
less favourable economic circumstances. The latter re-
sults, coupled with the fact that those with lost PLYs due
to IHD pay $0 in (median) tax per week, are also likely
to be a concern for the government in regards to the in-
creased number of people who will be out of the labour
force due to ill-health (reduced labour supply) and
whether the government will have sufficient funds to
meet the healthcare, income and other needs of those
too sick to work in the future.
From 2015 to 2030, people with lost PLYs due to IHD
are projected to experience the largest decline in income
of all groups, compared to those employed full-time
without IHD. Estimates from the counterfactual simula-
tion for differences in projected income of those with
lost PLYs due to IHD versus those in full-time employ-
ment without IHD (matched by age, sex and highest
level of education) suggest that those out of the labour
force due to IHD will receive AU$950.30 (US$914.06)
(95% confidence interval CI: AU$774.57; AU$1196.15)
less per week than those employed full-time without
IHD in 2015, increasing to AU$1269.82 (US$ 1221.39)
less per week (95%CI: AU$1083.01; AU$1545.95) by
2030 (Table 2) (a 63.94% increase in the relative differ-
ence between the total incomes). This widening of the
income gap is mainly due to wages growing faster than
the indexation of welfare payments (DSP). People with
lost PLYs due to IHD also receive more in welfare pay-
ments than those employed full-time without IHD in
2015 (an extra AU$316.30 (US$304.24) per week,
95%CI: AU$307.17; AU$322.70), increasing to an extra
AU$350.95 (US$337.57) per week (95%CI: AU$343.37;
AU$356.02) by 2030. The difference in extra welfare
payments received by those with lost PLYs due to IHD
and those employed full-time without IHD remains fairly
stable for all projected years because welfare payments
are assumed to have no real growth which is consistent
with the Australian Government’s policy of increasing
welfare payments (except for the Age Pension) in line
with national Consumer Price Index (CPI) (Table 2).
People with lost PLYs due to IHD paid significantly less
in income tax ($256.10 or US$246.33 per week, 95%CI:
AU$202.38; AU$329.41) compared to those working
full-time without IHD in 2015, with the difference in-
creasing to AU$335.73 (US$322.93) per week (95%CI:
AU$278.03; AU$415.64) by 2030 (a 31.09% increase in
lost taxes from this group).
National costs of IHD to individuals and the government
The projected national costs of IHD through lost labour
force participation consisted of AU$273 million (US$284
million) (95%CI: AU$218 million; AU$345 million) in
lost income in 2015, increasing to AU$443 million
(US$426 million) (95%CI: AU$360 million; AU$539 mil-
lion) in 2030 (i.e. 62.27% increase over 15 years) (Fig. 2).
Additional welfare payments because of lost labour force
participation due to IHD are projected to increase by
34.91% over this period, from AU$106 million (US$102
million) (95%CI: AU$101 million; AU$110 million) in
2015 to AU$143 million (95%CI: AU$138 million;
AU$147 million) in 2030 (Fig. 3). Finally, lost annual
taxation revenue is projected to increase by about
58.12% in real terms, from AU$74 million US$71 mil-
lion) (95%CI: AU$58 million; AU$96 million) in 2015 to
AU$117 million (US$113 million) (95%CI: AU$93 mil-
lion; AU$147 million) in 2030 (Fig. 4).
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Costs of IHD to society
As a result of the 6700 workers aged 45–64 withdrawing
from the labour force due to IHD in 2015, there was a
loss of AU$785 million (US$755 million) in GDP in that
year. In the same way, we projected GDP losses to be
AU$893 million (US$859 million), AU$987 million
(US$949 million) and AU$1125 million (US$1082 mil-
lion) in 2020, 2025 and 2030, respectively (Table 3).
Discussion
The national impacts of IHD through the loss of labour
force participation among 45–64 year olds was projected
to increase over the next 15 years, with a 62.27% in-
crease in lost personal income, which grew faster than
the 43.91% growth in welfare payments due to the in-
dexation of welfare payments being less than expected
wages growth; and a 43.31% increase in lost GDP. To
Table 2 Differences in economic measures between people with lost PLYs due to IHD and those employed full-time without IHD,
$AU2013
Labour force status 2015 2020 2025 2030
$ difference 95% CI $ difference 95% CI $ difference 95% CI $ difference 95% CI
Weekly total income (AU$) of individuals
Not in the labour force due
to IHD compared to employed
full-time without IHD
−950.30 (−1196.15;-
774.57)
− 1006.66 (− 1232.92;-
825.31)
− 1135.72 (− 1394.86;-
946.98)
−1269.82 (−1545.95;-
1083.01)
Not in the labour force due to
IHD compared to employed
part-time without IHD
− 264.56 (− 446.28;-
154.55)
− 289.07 (−465.82;-
176.86)
− 342.53 (− 541.90;-
228.38)
− 397.29 (− 572.50;-
270.40)
Weekly welfare income (AU$) received by individuals
Not in the labour force due
to IHD compared to employed
full-time without IHD
316.30 (307.17;
322.70)
329.38 (320.07;336.21) 337.38 (328.13;343.33) 350.95 (343.37;
356.02)
Not in the labour force due to
IHD compared to employed
part-time without IHD
269.33 (246.80;288.41) 282.92 (262.17;301.56) 293.40 (274.08;311.28) 308.20 (288.55;
325.48)
Weekly tax paid (includes Medicare levy) (AU$) by individuals
Not in the labour force due
to IHD compared to employed
full-time without IHD
−256.10 (−329.41;
−202.38)
−270.11 (− 340.80;-
217.15)
−301.35 (− 379.37;-
243.72)
−335.73 (−415.64;-
278.03)
Not in the labour force due to
IHD compared to employed
part-time without IHD
−63.53 (−98.59;-41.31) −70.76 (−103.88;-
45.91)
−77.93 (− 116.44;-
53.49)
−86.94 (− 121.71;-
86.94)
Fig. 2 Lost income through lost productive life years because of ischemic heart disease 2015–2030, $AU millions
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our knowledge, these are the first projections of the in-
direct costs of IHD in Australia.
The key advantage of developing large-scale microsi-
mulation models based on unit record data from nation-
wide surveys undertaken by a national Bureau of
Statistics is that they can be used to generate reliable in-
formation about the size and characteristics of subpopu-
lations [35]. This is due to the fact that they can imitate
the heterogeneity in the population by means of the na-
tional sample surveys. By reweighting the input data, it
is also possible to project this information several years
ahead. Other advantages are that microsimulation
models can be built to replicate the sophistication of
policy settings and/or financial and other systems and
thereby be used to predict outcomes arising from
changes to these settings and/or systems. This is
achieved through setting up various “what if” scenarios
with the results describing what the outcomes are, under
certain assumptions, for individuals or subgroups [36].
The primary objective of Health&WealthMOD2030 is to
Fig. 3 Lost welfare payments through lost productive life years because of IHD 2015–2030, $AU millions
Fig. 4 Lost taxes through lost productive life years because of ischemic heart disease 2015–2030, $AU millions
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project the number of Australians aged 45–64 years with
various chronic diseases (such as IHD) and the costs of
non-participation in the labour force due to ill-health
out to 2030, which will enable the government to better
prepare for future healthcare needs.
This study has some limitations. One is that the results
from Health&WealthMOD2030 are based on SDAC re-
spondents’ self-reported work status and chronic condi-
tions, though self-reported employment status and
health are regarded as reliable measures for costing
studies [37, 38]. Another is that the SDACs are cross-
sectional surveys; however, some sections of the surveys
were designed in a way that enables identification of
causal relationships. For example, the SDACs have ‘own
ill-health or disability’ as a category for the main reason
people are out of the labour force which made it possible
to identify workers who retired early due to their ill-
health in this study. Another is that the static microsi-
mulation modelling method and the SDACs 2003 and
2009 do not capture or model mortality, and therefore
the study did not estimate the impact of mortality on
labour force participation.
Few studies have examined the indirect costs of IHD
in the same level of detail as in this study. Guico-Pabia
et al. (2001) estimated the indirect costs of IHD using
the human capital approach (as in this study), and
adopting the perspective of the employer in private in-
dustry in the United States. Several national databases
were explored, and the indirect cost consisted of the
costs due to morbidity (lost productivity, idle assets, and
nonwage factors resulting from absenteeism) and mor-
tality (costs of replacing and retraining workers). The
total indirect cost of IHD to employers in private indus-
try was $182.74 per enrolee; and 95% of the indirect cost
was the consequence of lost work due to morbidity costs
[39]. In Australia, Deloitte Access Economics (2011) es-
timated the costs of lost labour force participation and
early mortality due to acute coronary syndrome (a sub-
set of IHD) to be $2.1 billion across all age groups in
2010 [5]. However, these studies have only used average
earnings for the population to estimate lost productivity
and have not estimated the costs to the individual nor
projected costs into the future; and they have not esti-
mated taxes and welfare costs.
The current study has quantified the national costs of
lost PLYs due to IHD to the Australian Government in
terms of lost income tax revenue and increased welfare
payments, and we would argue that prevention strategies
for IHD will likely be more cost-effective when these
additional costs are also considered. There are many pri-
mary and secondary prevention strategies (lifestyle mod-
ifications and pharmacological treatments [40], as well
as population-level interventions (such as fiscal interven-
tions to improve diets [41] and improving urban infra-
structure for active transport [42]) that have been shown
to be effective for IHD. Although some of the strategies
that reduce the incidence of IHD may be considered “ex-
pensive” from the perspective of the national health sys-
tem, it is highly likely that if productivity losses were
included in economic evaluations, they would demon-
strate cost-effectiveness (see, for example, Grover et al.
(2003) [43]). The productivity impact is particularly im-
portant for governments facing severe deficits and in
need of implementing resource effective strategies to
prevent and treat chronic conditions [44].
Lost productive life years (PLYs) is a relatively new
metric of disease burden and one that we have valued in
terms of lost income to individuals, extra welfare pay-
ments and lost tax revenue to the government, and lost
GDP to society. Both this measure and its multidimen-
sional valuation are not considered in most health eco-
nomics research. To widen the usefulness of the
valuation of lost PLYs due to chronic diseases, we have
valued these lost PLYs from the different perspectives of
the patient, the government, and society. Undoubtedly,
the inclusion of indirect costs either as a benefit (de-
nominator of the ICER) or cost (numerator of the ICER)
has an impact on cost-effectiveness analyses. The recent
shift in the United States’ recommendations on cost ef-
fectiveness analysis emphasises a change from not in-
cluding productivity costs to now including them [17,
18]. This shift in policy highlights a particular need for
the cost inputs presented in this paper.
In addition to the costs to governments, there are sig-
nificant costs to individuals who have exited from the
labour force due to IHD. The reduced income as a result
of exiting from the labour force is likely to reduce these
individuals’ living standards – lost income among those
with ill-health has been associated with a higher risk of
falling below the poverty line [45] and having inadequate
savings for retirement. [46] In Australia, it has been re-
ported that older workers who have retired early due to
Table 3 Lost Gross Domestic Product (millions) due to lost potential workers with ischemic heart disease, 2015–2030
2015 2020 2025 2030
Projected GDPa $1,483,861 $1,678,852 $1,899,467 $2,149,073
Lost GDP due to lost productive life yearsa $785 $893 $987 $1125
Potential % gain in GDP if those with lost PLYs due to IHD were able to remain in the labour force 0.05% 0.05% 0.05% 0.05%
Note: a Impacts on GDP are based on projections of 6700, 7300, 7600 and 8100 people aged 45–64 being out of the labour force due to IHD in 2015, 2020, 2025
and 2030, respectively
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CVD have significantly less personal wealth, and signifi-
cantly lower savings by the time they reach the traditional
retirement age of 65 years than those who remained
healthy and were able to stay in the labour force [12, 13].
Working capacity is currently an overlooked aspect of
recovery for heart failure, and indeed IHD or CVD more
generally [9]. Rørth et al. (2016) examined the likelihood
of people returning to work following first-time hospital-
isation for heart failure using a Danish cohort. They sug-
gest there are a range of reasons why return to work
rates are low for people who have experienced heart fail-
ure, including the physical functioning limitations of the
disease or comorbidities and the psychological effects of
having been diagnosed with heart failure. Cowie (2016)
maintains that the healthcare teams assisting patients
who have experienced heart failure often do not consider
the patient’s return to work to be possible, they are ap-
prehensive about the risks for patients returning to
work, or do not have competence in employment coun-
selling or restoration. To promote the patient’s working
capacity as a central and desirable feature of rehabilita-
tion, Cowie (2016) argues that working capacity would
need to be considered at each point in the patient’s jour-
ney from the first-time hospitalisation to returning to
work, and for there to be ongoing engagement from the
relevant stakeholders (i.e. the patient, their family, and
their employer) at these different points [9]. Recent
studies from a cross-sectional survey of people on sick
leave due to heart failure in Sweden suggest that con-
structive encounters between healthcare professionals
and social insurance officers are associated with patient’s
having an improved perception of their likely ability to
return to work [47, 48].
In order to minimise the costs of lost PLYs due to
IHD reported in this paper, greater investment in IHD
prevention and other strategies that include working
capacity as a central feature are recommended. This ap-
proach aligns with the health platform of the Australian
Government which emphasises that better prevention
and/or treatment strategies for chronic disease can not
only improve health outcomes for individuals but eco-
nomic outcomes for individuals and the nation [34, 49].
Conclusions
Ischemic heart disease has a significant impact on not
only quality of life but also on the earning prospects of
those with the chronic disease. Developing and imple-
menting effective health interventions to improve the
health outcomes of those with IHD and, in turn, their
labour market participation should be a focus for public
health.
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